ZimVie's $1B sales forecast, Aurora Spine's patent nod and more: 4 device company notes

Spinal Tech

How Zimmer Biomet performed in the fourth quarter of 2021 and three more updates from spine and orthopedic device companies:

1. Orthobiologics technology company Bone Solutions received FDA 510(k) clearance for its Mg Osteorevive bone void filler.

2. Zimmer Biomet saw a 2.3 percent dip in its fourth-quarter sales year over year and set a completion date of March 1 for its spine and dental spinoff, ZimVie. Read more details here.

3. Aurora Spine received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent related to the ZipFlex device.

4. Zimmer Biomet's spine and dental spinoff, ZimVie, is expected to earn $1 billion in revenue, with an adjusted EBITDA margin of 13.1 to 13.6 percent.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers